Staphylococcal and streptococcal toxic shock and kawasaki syndromes

Clinical Infectious Disease

Volumn , Issue , 2010, Pages 129-134

  Assimacopoulos, Aristides P ^a   Schlievert, Patrick M ^b  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 81555216444     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511722240.019     Document Type: Chapter

References (5)

1. Darenberg J, Soderquist B, Henriques Normark B, et al. Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens: Implications for therapy of toxic shock syndrome. Clin Infect Dis. 2004;38:836-842.
2. Mason WH, Takahashi M. Kawasaki syndrome. Clin Infect Dis. 1999;28:169-1878.
3. Pickering LK, et al., eds. 2006 Report of the Committee on Infectious Diseases of the American Academy of Pediatrics (The Red Book). 27th ed. Elk Grove, IL: American Academy of Pediatrics; 2006:412-415.
4. Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment and longterm management of Kawasaki disease: A statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association, Circulation. 2004;110:2747-2771.
5. The Prevention of Invasive Group A Streptococcal Infections Workshop Participants. Prevention of invasive group A strepotococcal disease among household contacts of case patients and among postpartum and postsurgical patients: recommendations from the Centers for Disease Control and Prevention. Clin Infect Dis. 2002;35: 950-959.